发布求助
文献互助 智能选刊 最新文献

Radiation Oncology Journal最新文献

筛选
英文 中文
Implementing high-dose rate surface mould brachytherapy for carcinoma of eyelid: a practical approach and weekly review 针对眼睑癌实施高剂量率表面模式近距离放射治疗：实用方法与每周回顾
IF 2.3
Radiation Oncology Journal Pub Date : 2024-03-04 DOI: 10.3857/roj.2023.00682
K. Patro, A. Avinash, Arya Banidutta, C. Kundu, Partha Sarathi Bhattacharya, V. Pilaka, Mrutyunjayarao Muvvala, AyyalasomayajulaAnil Kumar, Srinu Aketi, Keerthiga Karthikeyan, Bhargava Krishna Madasu, Dona Treesa Vincent
{"title":"Implementing high-dose rate surface mould brachytherapy for carcinoma of eyelid: a practical approach and weekly review","authors":"K. Patro, A. Avinash, Arya Banidutta, C. Kundu, Partha Sarathi Bhattacharya, V. Pilaka, Mrutyunjayarao Muvvala, AyyalasomayajulaAnil Kumar, Srinu Aketi, Keerthiga Karthikeyan, Bhargava Krishna Madasu, Dona Treesa Vincent","doi":"10.3857/roj.2023.00682","DOIUrl":"https://doi.org/10.3857/roj.2023.00682","url":null,"abstract":"eyelid carcinoma","PeriodicalId":46572,"journal":{"name":"Radiation Oncology Journal","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140080691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of high-dose radiation therapy on bone: a scoping review 大剂量放射治疗对骨骼的影响：范围综述
IF 2.3
Radiation Oncology Journal Pub Date : 2024-02-27 DOI: 10.3857/roj.2023.00969
Lawrence Berk
{"title":"The effects of high-dose radiation therapy on bone: a scoping review","authors":"Lawrence Berk","doi":"10.3857/roj.2023.00969","DOIUrl":"https://doi.org/10.3857/roj.2023.00969","url":null,"abstract":"and clinical data","PeriodicalId":46572,"journal":{"name":"Radiation Oncology Journal","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140425127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of Combs prognostic scoring system in Indian recurrent glioma patients treated with re-radiation 在接受再放射治疗的印度复发性胶质瘤患者中验证康布斯预后评分系统
IF 2.3
Radiation Oncology Journal Pub Date : 2024-01-23 DOI: 10.3857/roj.2023.00542
Debnarayan Dutta, Meenu Jose, S. Kalavagunta, A. Sasidharan, Haridas Nair, A. Edappattu
{"title":"Validation of Combs prognostic scoring system in Indian recurrent glioma patients treated with re-radiation","authors":"Debnarayan Dutta, Meenu Jose, S. Kalavagunta, A. Sasidharan, Haridas Nair, A. Edappattu","doi":"10.3857/roj.2023.00542","DOIUrl":"https://doi.org/10.3857/roj.2023.00542","url":null,"abstract":"Hypo-RT, and UF-RT cohort was 18.8 months (range, 2.4 to 76.8); 6.6 months (range, 2 to 17.4), and 13.9 months (range, 3 to 131.9). Median OS as per Combs criteria were 16.6 months (Group a), 24.6 months (Group b), 4.6 months (Group c), and 3 months (Group d). Significant survival benefit was with good KPS score (KPS >80 vs. <80; 20.46 vs. 5.25 months; p < 0.001), patients receiving salvage chemotherapy (20.46 vs. 6.96 months; p = 0.001), and patients received re-RT biological equivalent dose (BED 3 ) >80 Gy (16.62 vs. 5.48 months; p = 0.03). Median overall survival (OS) in our patient cohort and Combs cohort in Group a was 16.6 and 19.5 months; Group b was 24.6 and 11.3 months; Group c was 4.7 and 8.1 months, and Group d was 2 and 5.5 months, respectively. Six months survival in our patient cohort and Combs cohort in Groups a, b, c, d were 100%, 92%, 34%, 17% and 94%, 79%, 70%, 41%, respectively. Twelve months survival in our patient cohort and Combs cohort in Groups a, b, c, d were 88%, 74%, 22%, 0% and 88%, 47%, 22%, 7%, respectively. Conclusion: Modified Combs prognostic factors predicts OS and is applicable in Indian subcontinent patient population.","PeriodicalId":46572,"journal":{"name":"Radiation Oncology Journal","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139605179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term toxicities after allogeneic hematopoietic stem cell transplantation with or without total body irradiation: a population-based study in Korea 同种异体造血干细胞移植后的长期毒性：韩国一项基于人群的研究
IF 2.3
Radiation Oncology Journal Pub Date : 2024-01-16 DOI: 10.3857/roj.2023.00871
J. Kwon, Byoung Hyuck Kim
{"title":"Long-term toxicities after allogeneic hematopoietic stem cell transplantation with or without total body irradiation: a population-based study in Korea","authors":"J. Kwon, Byoung Hyuck Kim","doi":"10.3857/roj.2023.00871","DOIUrl":"https://doi.org/10.3857/roj.2023.00871","url":null,"abstract":"hypo-thyroidism (1.50; 95% CI, 1.1–2.1) were significantly increased after TBI. However, there were no significant differences in the occurrence of myocardial infarction and stroke according to TBI. Conclusions: Our results suggest that modern TBI may not additionally increase the risk of SC after allogeneic HSCT, although increased risks of other diseases were noted. Physicians should carefully consider individualized risks and benefits of TBI, with a particular focus by age group.","PeriodicalId":46572,"journal":{"name":"Radiation Oncology Journal","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139618556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Different approaches to target volume definition and boost delivery in surgery de-escalation clinical trial in breast cancer patients with pathological complete response 在对病理完全反应的乳腺癌患者进行手术去升级临床试验时，采用不同的方法来确定靶区容积和提供助推剂
IF 2.3
Radiation Oncology Journal Pub Date : 2023-12-31 DOI: 10.3857/roj.2023.00528
S. Novikov, Petr Krivorotko, Zhanna Bryantseva, I. Akulova, A. Emelyanov, V. Mortada, Olga Ponomareva, P. Krzhivitskiy, Sergey Kanaev
{"title":"Different approaches to target volume definition and boost delivery in surgery de-escalation clinical trial in breast cancer patients with pathological complete response","authors":"S. Novikov, Petr Krivorotko, Zhanna Bryantseva, I. Akulova, A. Emelyanov, V. Mortada, Olga Ponomareva, P. Krzhivitskiy, Sergey Kanaev","doi":"10.3857/roj.2023.00528","DOIUrl":"https://doi.org/10.3857/roj.2023.00528","url":null,"abstract":"Purpose: We evaluate various approaches to target volume definition and boost delivery in patients with complete response to neoadjuvant systemic therapy (NST) who were treated by radiotherapy without a surgery. Materials and Methods: A pathological complete response (pCR) was diagnosed in 21 of 27 patients included in “surgery de-escalation” prospective observation study. Clips were placed in the primary tumor volume (PrTV) before NST and during the vacuum aspiration biopsy. Twenty patients with pCR underwent the whole breast irradiation and a boost to the PrTV. High-dose rate brachytherapy (HDRB) was the basic technique for boost delivery. Finally, we identified the value of fused images (computed tomography [CT] before NST with simulation CT), clips and their combination for an accurate boost delivery.Results: A complete overlap between PrTV on pre-treatment CT with the localization of the clips on simulation CT was mentioned in 10, partial mismatch in three patients. In 12 of these 13 women, HDRB was successfully used for the boost delivery. In five cases we mentioned a marked discrepancy between the PrTV on fused images and the topography of the clips. In other two women we did not find clips on simulation CT. The fused images in five of these seven patients showed anatomical landmarks (scar, fibrosis) used for identification of the gross tumor volume. In all 20 women with pCR (average follow-up of 16.6 months), there were no locoregional recurrences.Conclusion: Combination of the clips with fusion of pre-NST and simulation CTs is important for an accurate boost delivery.","PeriodicalId":46572,"journal":{"name":"Radiation Oncology Journal","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139135845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proton beam therapy as a promising option for high-risk limited stage small cell lung cancer: revealing potential of future novel agents 质子束疗法是治疗高风险局限期小细胞肺癌的理想选择：揭示未来新型制剂的潜力
IF 2.3
Radiation Oncology Journal Pub Date : 2023-12-31 DOI: 10.3857/roj.2023.01004
C. H. Rim
{"title":"Proton beam therapy as a promising option for high-risk limited stage small cell lung cancer: revealing potential of future novel agents","authors":"C. H. Rim","doi":"10.3857/roj.2023.01004","DOIUrl":"https://doi.org/10.3857/roj.2023.01004","url":null,"abstract":"Radiotherapy (RT) is the main local treatment for limited-stage small-cell lung cancer (LS-SCLC). No-tably, SCLC is extremely sensitive to radiotherapy. Turrisi et al. [1] demonstrated the oncological benefit of high radiation doses by showing the survival benefit of a 45 Gy/1.5 Gy bid protocol compared to the conventional 45 Gy in 25 fractions treatment. Recently, Faivre-Finn et al. [2] reported that treatment with 66 Gy in 33 fractions could achieve a survival similar to that of the bid regimen. Ref-erencing the literature on non-small cell lung cancer (NSCLC), dose-escalation beyond 60–66 Gy is not always successful and has the potential to increase toxicity [3","PeriodicalId":46572,"journal":{"name":"Radiation Oncology Journal","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139135630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Target movement according to cervical lymph node level in head and neck cancer and its clinical significance 根据头颈癌颈部淋巴结水平确定的目标移动及其临床意义
IF 2.3
Radiation Oncology Journal Pub Date : 2023-12-20 DOI: 10.3857/roj.2023.00787
H. Choi, B. Jeong, Hojin Jeong, I. Ha, Bong-Hoi Choi, K. Kang
{"title":"Target movement according to cervical lymph node level in head and neck cancer and its clinical significance","authors":"H. Choi, B. Jeong, Hojin Jeong, I. Ha, Bong-Hoi Choi, K. Kang","doi":"10.3857/roj.2023.00787","DOIUrl":"https://doi.org/10.3857/roj.2023.00787","url":null,"abstract":"mm for neck LN level II, 5 mm for neck LN level III, and 3 mm for neck LN level IV was required to include all movements of each LN level. In patients using bite block, changes in primary tumor volume, and metastatic LN volume were related to significant movement.","PeriodicalId":46572,"journal":{"name":"Radiation Oncology Journal","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138957982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of radiotherapy techniques in patients with thymic epithelial tumor who underwent postoperative radiotherapy 胸腺上皮肿瘤患者术后放疗技术比较
IF 2.3
Radiation Oncology Journal Pub Date : 2023-12-15 DOI: 10.3857/roj.2023.00360
Hyunseok Lee, D. Oh, Y. Ahn, Hongryull Pyo, Kyungmi Yang, J. Noh
{"title":"Comparison of radiotherapy techniques in patients with thymic epithelial tumor who underwent postoperative radiotherapy","authors":"Hyunseok Lee, D. Oh, Y. Ahn, Hongryull Pyo, Kyungmi Yang, J. Noh","doi":"10.3857/roj.2023.00360","DOIUrl":"https://doi.org/10.3857/roj.2023.00360","url":null,"abstract":"lower mean lung dose (4.4 Gy vs. 7.6 Gy vs. 10.9 Gy, respectively; p < 0.001), lower mean heart dose (5.4 Gy vs. 10.0 Gy vs. 13.1 Gy, respectively; p = 0.003), and lower mean esophageal dose than patients in the 3D-CRT and IMRT groups (6.3 Gy vs. 9.8 Gy vs. 13.5 Gy, respectively; p = 0.011). Twenty patients (19.8%) showed disease recurrence, and seven patients (6.9%) died. The differences in the survival rates between RT groups were not statistically significant. Conclusion: In patients with TET who underwent adjuvant RT, PBT resulted in a lower dose of exposure to adjacent organs at risk. Survival outcomes for patients in PBT group were not significantly different from those in other groups.","PeriodicalId":46572,"journal":{"name":"Radiation Oncology Journal","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139000734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary function and toxicities of proton versus photon for limited-stage small cell lung cancer 质子与光子治疗局限期小细胞肺癌的肺功能和毒性比较
IF 2.3
Radiation Oncology Journal Pub Date : 2023-12-06 DOI: 10.3857/roj.2023.00773
Sang Hoon Seo, Hongryull Pyo, Yong Chan Ahn, D. Oh, Kyungmi Yang, Nalee Kim, Jong-Mu Sun, Sehhoon Park, H. Jung, Se-Hoon Lee, J. Ahn, Myung-Ju Ahn, J. Noh
{"title":"Pulmonary function and toxicities of proton versus photon for limited-stage small cell lung cancer","authors":"Sang Hoon Seo, Hongryull Pyo, Yong Chan Ahn, D. Oh, Kyungmi Yang, Nalee Kim, Jong-Mu Sun, Sehhoon Park, H. Jung, Se-Hoon Lee, J. Ahn, Myung-Ju Ahn, J. Noh","doi":"10.3857/roj.2023.00773","DOIUrl":"https://doi.org/10.3857/roj.2023.00773","url":null,"abstract":"and radiation-related toxicities in LS-SCLC. PBT may be a valuable therapeutic modality in patients with poor pulmonary function or extensive disease burden owing to its lung-sparing ability.","PeriodicalId":46572,"journal":{"name":"Radiation Oncology Journal","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138596485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CyberKnife-based stereotactic radiosurgery or fractionated stereotactic radiotherapy in older patients with brain metastases from non-small cell lung cancer 在非小细胞肺癌脑转移的老年患者中使用基于 CyberKnife 的立体定向放射手术或分次立体定向放射治疗
IF 2.3
Radiation Oncology Journal Pub Date : 2023-11-28 DOI: 10.3857/roj.2023.00563
Jeongshim Lee, H. Kim, Woo Chul Kim
{"title":"CyberKnife-based stereotactic radiosurgery or fractionated stereotactic radiotherapy in older patients with brain metastases from non-small cell lung cancer","authors":"Jeongshim Lee, H. Kim, Woo Chul Kim","doi":"10.3857/roj.2023.00563","DOIUrl":"https://doi.org/10.3857/roj.2023.00563","url":null,"abstract":"clinical results of CyberKnife","PeriodicalId":46572,"journal":{"name":"Radiation Oncology Journal","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139224037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信